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CASE STUDY
Talc seromadesis in patients with chronic 
seroma formation after breast surgery
Coriene J. L. M. Catsman* , Martinus A. Beek and Arjen M. Rijken
Abstract 
Background: Seroma formation, after breast surgery is a commonly seen complication with an incidence ranging 
from 10 to 85 %. In general, though seroma usually disappears within several weeks, some patients are troubled with 
chronic seroma. Seroma predisposes to infection leading to wound related complications and may also delay adju-
vant chemoradiation, leading to less effective breast cancer treatment.
Case description: A 52-years-old Dutch woman presenting with a pT3N1M0 infiltrating lobular breast carcinoma 
received neo-adjuvant chemotherapy, following modified radical mastectomy with sentinel node procedure. She suf-
fered from chronic seroma formation, delaying adjuvant radiation therapy. We successfully performed talc seromade-
sis to eliminate seroma formation. During six-month follow-up, no seroma was detected.
Discussion and evaluation: Talc seromadesis after breast surgery is a rarely described in literature. In order to 
develop this technique further research aimed to evaluate its effectiveness on safety and possible later breast recon-
struction must be carried out.
Conclusion: Talc seromadesis may be a safe, cost effective and minimally invasive solution to treat chronic seroma 
after breast surgery.
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Background
Seroma formation after breast surgery is a commonly 
seen complication with an incidence ranging from of 10 
to 85  %. The incidence of seroma formation has been 
shown to correlate with age, hypertension and breast 
size, and it may be operator and technique dependent 
(Kuroi et al. 2005). In general, though seroma usually dis-
appears within several weeks, some patients are troubled 
with chronic seroma requiring continued seroma aspi-
ration. It is assumed that seroma formation is caused by 
insufficient lymph drainage. Seroma predisposes to infec-
tion leading to wound related complications and may also 
delay adjuvant chemoradiation, leading to less effective 
breast cancer treatment (McCaul et al. 2000).
Seroma formation is a commonly seen complication 
following breast surgery in our surgical center. In this 
case report we describe a patient with chronic seroma 
formation after breast surgery who is successfully treated 
with talc seromadesis.
Case description
A 52-years-old Dutch woman presenting with a 
pT3N1M0 infiltrating lobular breast carcinoma received 
neo-adjuvant chemotherapy, following modified radical 
mastectomy with sentinel node procedure. She suffered 
from chronic seroma formation. During initial surgery 
two drains were placed in both the mammary region and 
the axillary region. The drain positioned in the mam-
mary region was removed 3 days after surgery because of 
minor liquid collection. The drain positioned in the axil-
lary region was removed 12  days after surgery because 
of production of less than 30 mL a day. Seroma was first 
detected 14 days after surgery, being aspirated at day 24 
after surgery. During a period of two and a half months 
seroma was aspirated nine times. Because of recur-
rent seroma formation adjuvant radiation therapy was 
delayed.
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In order to continue breast cancer treatment, we tried 
to find an effective solution to eliminate seroma forma-
tion. Currently, there is no evidence based standardized 
procedure for treating chronic seroma. Several tech-
niques to solve chronic seroma formation such as surgi-
cal closure of the dead space between skin and thorax 
wall (O’Dwyer et  al. 1991), talc seromadesis of the ser-
oma cavity (Saeb-Parsy et  al. 2006), tetracycline sclero-
therapy (Taghizadeh et al. 2008) and wound closure with 
a quilting technique (Sajid et al. 2011).
In consultation with the patient and our breast surgery 
team we decided to perform talc seromadesis because 
this procedure is described as an effective solution to 
treat seroma formation (Saeb-Parsy et al. 2006).
Technique description
Under full anesthesia, a 5  cm long lateral incision was 
made in the line of the previous operation wound. Steri-
lized dry talc powder was insufflated into the wound 
(Figs. 1 and 2). A drain was positioned and a compression 
bandage was assembled.
Result
The compression bandage and drain were removed 
1  week after the procedure and collected a total of 
145 mL. Both the procedure and recovery of the patient 
were without complications. Three weeks after talc sero-
madesis, the patient was fully recovered (Fig. 3). During 
6 month follow-up, no seroma recurred. The patient was 
able to continue with adjuvant chemoradiation.
Discussion and evaluation
Talc seromadesis is inspired by pleurodesis and is a 
widely accepted technique to treat pleural effusion and 
recurrent pneumothorax. In talc seromadesis, talc is 
used as a sclerotic agent which induces a fibrotic reac-
tion, causing adhesion between skin and thoracic wall 
(Saeb-Parsy et al. 2006, Rodriguez-Panadero and Antony 
1997).
Talc seromadesis after breast surgery is a poorly 
described subject in literature. It appears to be a safe, 
cost-effective and minimal invasive method solution to 
treat chronic seroma formation after breast surgery. In 
order to develop this technique further research aimed 
to evaluate its effectiveness on safety and possible later 
breast reconstruction must be carried out.
Conclusion
Talc seromadesis may be a safe, cost effective and mini-
mally invasive solution to treat chronic seroma formation 
after breast surgery.
Consent
Written informed consent was obtained from the patient 
for publication of this case report and any accompanying 
Fig. 1 Talc insuflatting device
Fig. 2 Talc insuflattion into operation wound
Fig. 3 Result one-month after talc seromadesis
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images. A copy of the written consent is available for 
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